Skip to search boxSkip to navigationSkip to main content

Guillain–Barre syndrome outbreak in Peru: Association with polymorphisms in IL-17, ICAM1, and CD1

  • Luis Jaramillo-Valverde
    ,
  • Kelly S. Levano
    ,
  • Isolina Villanueva
    ,
  • Meylin Hidalgo
    ,
  • Marco Cornejo
    ,
  • Pilar Mazzetti
*Corresponding author for this work
  • Universidad Peruana Cayetano Heredia
    ,
  • ALBIOTEC
    ,
  • INBIOMEDIC Research and Technological Center
    ,
  • Hospital Belén de Trujillo
    ,
  • docencia y atención especializada en epilepsia
    ,
  • Universidad Nacional Mayor de San Marcos
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

e00960

Journal (Volume, Issue Number)

Molecular Genetics and Genomic Medicine (Volume 7, Issue 10)

Publication milestones

  • Published - 01/10/2019

Publication status

Published - 01/10/2019

Publication IDs

  • Scopus: 85071289752
  • PubMed: 31464097

Abstract

Background: Guillain–Barre Syndrome (GBS) is considered a complex disorder with significant environmental effect and genetic susceptibility. Genetic polymorphisms in CD1E, CD1A, IL-17, and/or ICAM1 had been proposed as susceptibility genetic variants for GBS mainly in Caucasian population. This study explores the association between selected polymorphisms in these genes and GBS susceptibility in confirmed GBS cases reported in mestizo population from northern Peru during the most recent GBS outbreak of May 2018. Methods: A total of nine nonrelated cases and 11 controls were sequenced for the polymorphic regions of CD1A, CD1E, IL-17, and ICAM1. Results: We found a significant protective association between heterozygous GA genotype in ICAM1 (241Gly/Arg) and GBS (p '.047). IL-17 was monomorphic in both controls and patients. No significant differences were found in the frequency of SNPs in CD1A and CD1E between the group with GBS patients and healthy controls. Conclusion: ICAM1 polymorphisms might be considered as potential genetic markers of GBS susceptibility. Further studies with larger sample size will be required to validate these findings.

Funding Details

We are grateful to all the study participants. This work was supported financially by INBIOMEDIC, Universidad de Huánuco, UTEC, and Gen Lab del Peru.
FundersFunding numbers
Gen Lab del Peru
-
INBIOMEDIC
-
UTEC
-
Universidad de Huánuco
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Citations
8
Captures
19